$ALEC 3 SEC Filings

Filed On	Filing
30 Jun 2025	Form 3: Berkley Neil Lindsay, Principal Financial Officer Holds 362,412 shares of Common Stock
30 Jun 2025	Form 3: Wong-Sarad Grace, Principal Accounting Officer Holds 109,358 shares of Common Stock
21 Mar 2024	Form 3: Altmeyer Mark, Director Holds 0 shares of No securities of the Issuer are beneficially owned.
21 Mar 2024	Form 3: Desouza Errol B, Director Holds 0 shares of No securities of the Issuer are beneficially owned.
31 May 2022	Form 3: Romano Gary, Chief Medical Officer No securities owned
09 Feb 2022	Form 3: Grasso Marc, Chief Financial Officer No securities owned
16 Dec 2021	Form 3: Kenkare-Mitra Sara, President and Head of R&D No securities owned
27 Sep 2021	Form 3: Garofalo Elizabeth A., Director No securities owned
09 Sep 2021	Form 3: Rubinstein Linda M, Interim Chief Financial Ofcr No securities owned
24 Mar 2020	Form 3: Hammond Paula, Director Holds 0 shares of No securities of the Issuer are beneficially owned.
12 Dec 2019	Form 3: Suliman Shehnaaz, President and COO Holds 0 shares of No securities of the Issuer are beneficially owned.
12 Aug 2019	Form 3: Yaffe Kristine, Director Holds 0 shares of No securities of the Issuer are beneficially owned.
06 Feb 2019	Form 3: Polaris Venture Management Co. VI, L.l.c., 10% owner and 4 others
06 Feb 2019	Form 3: Mcguire Terrance, Director
06 Feb 2019	Form 3: Gerngross Tillman U., Director Holds 2,181,318 shares of Common Stock
06 Feb 2019	Form 3: Oney Sabah, Chief Business Officer Holds 593,918 shares of Common Stock
06 Feb 2019	Form 3: Paul Robert, Chief Medical Officer Holds 333,719 shares of Common Stock
06 Feb 2019	Form 3: King Robert, Chief Development Officer Holds 537,317 shares of Common Stock
06 Feb 2019	Form 3: Scheller Richard H, Director Holds 19,981 shares of Common Stock
06 Feb 2019	Form 3: Orbimed Advisors Llc, Director and 1 other

Comments